Home › Amgen: Its biosimilar version of Humira about as effective
 

Keywords :   


Amgen: Its biosimilar version of Humira about as effective

2015-02-04 00:09:02| Biotech - Topix.net

Biologic drugmaker Amgen says its biosimilar version of rheumatoid arthritis drug Humira worked similarly in a key head-to-head test. Amgen Inc. says its ABP 501 produced similar results in the percentage of patients in the 26-week, late-stage study who saw improvements in pain, ability to function and number of swollen and tender joints.

Tags: version effective amgen humira

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Amazon at 30: What next for 'The Everything Company'?
05.07Atlantic Tropical Weather Outlook
05.07Could the 'flying piano' help transform air cargo?
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Forecast Discussion Number 25
04.07Hurricane Beryl Public Advisory Number 25
04.07Summary for Hurricane Beryl (AT2/AL022024)
More »